Invasive pulmonary aspergillosis associated with infliximab therapy.
Warris
A
A
Bjørneklett
A
A
Gaustad
P
P
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001228:Aspergillosis / Q000209:etiology*; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D003424:Crohn Disease / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D008172:Lung Diseases, Fungal / Q000209:etiology*; D008297:Male; D009894:Opportunistic Infections / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab